Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines
T. Gilliland, Y. Liu, R. Li, M. Dunn, E. Cottle, Y. Terada, Z. Ryckman, M. Alcorn, S. Vasilatos, J. D. Lundy, D. Larson, H. Wu, T. Luke, C. Bausch, K. Egland, , W. Klimstra
This study evaluates the neutralizing capacity and protective efficacy of human polyclonal IgG against SARS-CoV-2 variants in vitro and in a transgenic hamster model.
bioRxiv · Jul 26, 2021 · PreprintMicrobiology